Gerson; Stanton

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gerson; Stanton.The latest application filed is for "inhibitors of short-chain dehydrogenase activity for treating fibrosis".

Company Profile

8.16.21

Gerson; Stanton - Hunting Valley OH
Gerson; Stanton - Cleveland OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors Of Short-chain Dehydrogenase Activity For Treating Fibrosis App 20210283113 - Markowitz; Sanford ; et al.	2021-09-16
Compositions And Methods Of Modulating Short-chain Dehydrogenase Activity App 20210106587 - Markowitz; Sanford ; et al.	2021-04-15
Inhibitors of short-chain dehydrogenase activity for treating fibrosis Grant 10,945,998 - Markowitz , et al. March 16, 2	2021-03-16
Compositions And Methods Of Modulating 15-pgdh Activity App 20210032265 - Markowitz; Sanford ; et al.	2021-02-04
Compositions and methods of modulating short-chain dehydrogenase activity Grant 10,869,871 - Markowitz , et al. December 22, 2	2020-12-22
Methods of diagnosing and treating cancer Grant 10,722,530 - Gerson , et al.	2020-07-28
Methods of diagnosing and treating cancer Grant 10,725,042 - Gerson	2020-07-28
Compositions And Methods Of Modulating 15-pgdh Activity App 20200140453 - Markowitz; Sanford ; et al.	2020-05-07
Compositions And Methods Of Modulating Shirt-chain Dehydrogenase Activity App 20190365769 - Markowitz; Sanford ; et al.	2019-12-05
Compositions and methods of modulating 15-PGDH activity Grant 10,301,320 - Markowitz , et al.	2019-05-28
Methods Of Diagnosing And Treating Cancer App 20180185403 - Gerson; Stanton ; et al.	2018-07-05
Fluorescent Probes For Abasic Site Detection App 20180127830 - Gerson; Stanton ; et al.	2018-05-10
Inhibitors Of Short-chain Dehydrogenase Activity For Treating Fibrosis App 20180064694 - Markowitz; Sanford ; et al.	2018-03-08
Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis Grant 9,801,863 - Markowitz , et al. October 31, 2	2017-10-31
Compositions and methods of modulating short-chain dehydrogenase activity Grant 9,789,116 - Markowitz , et al. October 17, 2	2017-10-17
Compositions and methods of modulating 15-PGDH activity Grant 9,790,233 - Markowitz , et al. October 17, 2	2017-10-17
Inhibitors Of Short-chain Dehydrogenase Activity For Modulating Hematopoietic Stem Cells And Hematopoiesis App 20170216265 - Markowitz; Sanford ; et al.	2017-08-03
Compositions And Methods Of Modulating Short-chain Dehydrogenase Activity App 20170173028 - Markowitz; Sanford ; et al.	2017-06-22
Compositions And Methods Of Modulating 15-pgdh Activity App 20170165241 - Markowitz; Sanford ; et al.	2017-06-15
Antimetabolite Agent Combinations In The Treatment Of Cancer App 20170071965 - Liu; Lili ; et al.	2017-03-16
Antimetabolite agent combinations in the treatment of cancer Grant 9,498,489 - Liu , et al. November 22, 2	2016-11-22
Compositions And Methods Of Modulating 15-pgdh Activity App 20150072998 - Markowitz; Sanford ; et al.	2015-03-12
MGMT inhibitor combination for the treatment of neoplastic disorders Grant 8,791,081 - Liu , et al. July 29, 2	2014-07-29
Alkylating agent combinations in the treatment of cancer Grant 8,716,346 - Gerson , et al. May 6, 2	2014-05-06
Methods Of Diagnosing And Treating Cancer App 20140066464 - Gerson; Stanton	2014-03-06
Detection and quantification of abasic site formation in vivo Grant 8,367,332 - Liu , et al. February 5, 2	2013-02-05
Antimetabolite Agent Combinations In The Treatment Of Cancer App 20100267657 - LIU; LILI ; et al.	2010-10-21
Detection And Quantification Of Abasic Site Formation In Vivo App 20100111861 - Liu; Lili ; et al.	2010-05-06
Mgmt Inhibitor Combination For The Treatment Of Neoplastic Disorders App 20100093647 - Liu; Lili ; et al.	2010-04-15
Assay For Measurement Of Apurinic/apyrimidinic (ap) Sites And For Screening Ap-site Reactive Compounds App 20090298077 - Xu; Yan ; et al.	2009-12-03
Genetic markers in the HLA-C gene associated with an adverse hematological response to drugs App 20060183146 - Athanasiou; Maria ; et al.	2006-08-17
Genetic markers in the HLA-DQBI gene associated with an adverse hematological response to drugs App 20060177860 - Athanasiou; Maria ; et al.	2006-08-10
Genetic markers in the CSF2RB gene associated with an adverse hematological response to drugs App 20060178843 - Athanasiou; Maria ; et al.	2006-08-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.